Fig. 8
The effects of simvastatin on the TME of endometrial cancer. By suppressing TGF-β2, simvastatin inhibited the immunosuppressive effects of CaMSCs and enforced the cytotoxicity of NK cells against endometrial cancer cells.
Fig. 8 | Scientific Reports
